Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US MedPAC (Medicare Payment Advisory Committee) raises fears of less Medicare cash for new technologies

This article was originally published in Clinica

Executive Summary

US device lobbyists were exultant last year when they convinced lawmakers to lower Medicare's qualifying threshold for enhanced inpatient payments. Now there is an ominous warning in a new report by an influential congressional advisory group suggesting the provision in the Medicare Prescription Drug, Improvement and Modernization Act (MMA) could prove to be a pyrrhic victory for many in industry.

Topics

UsernamePublicRestriction

Register

MT057774

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel